论文部分内容阅读
近年来,文献报告BiPAP无创正压机械通气治疗各型呼吸衰竭收效甚好,但用于治疗急性肺水肿报告较少。我院ICU对2003年6月~2006年8月收治的32例急性肺水肿患者,早期使用BiPAP无创正压机械通气,取得了满意的疗效,且未见明显副作用。1 资料与方法1.1 临床资料所有64例患者均符合急性肺水肿诊断标准。按随机双盲法分为治疗组与对照组,每组各32例。治疗组中男22例,女10例,年龄18~82岁,平均年龄58±14.5岁;对照组男21例,女11例,年龄21~80岁,平均年龄60±15.8岁。两组患者临床资料经统计学处理无显著性差异,具有可比性。64例患者包括心源性肺水肿56例,基础
In recent years, the literature reports BiPAP noninvasive positive pressure mechanical ventilation for various types of respiratory failure has achieved good results, but less for the treatment of acute pulmonary edema. ICU of our hospital from June 2003 to August 2006 admitted to 32 patients with acute pulmonary edema, early use of BiPAP noninvasive positive pressure mechanical ventilation, and achieved satisfactory results, and no significant side effects. 1 Materials and Methods 1.1 Clinical data All 64 patients were in line with the diagnostic criteria of acute pulmonary edema. Randomized double-blind method was divided into treatment group and control group, 32 cases in each group. The treatment group, 22 males and 10 females, aged 18 to 82 years, mean age 58 ± 14.5 years; control group of 21 males and 11 females, aged 21 to 80 years, mean age 60 ± 15.8 years. There was no significant difference between the two groups in clinical data by statistical analysis, comparable. Sixty-four patients included cardiogenic pulmonary edema on 56 basis